RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML) trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients who have run out of options
Disease control Not yet recruitingThis early-stage study tests a new treatment called CT1390B for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The main goals are to check safety, find the right dose, and see if it helps control the disease. About 18 participant…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for Hard-to-Treat leukemia? early trial launches
Disease control Not yet recruitingThis early-stage study tests a new drug called CT0991 in 24 adults with acute myeloid leukemia that has come back or not responded to treatment. The main goals are to check safety, find the right dose, and see if it helps control the disease. Participants must be between 18 and 7…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA(AML)
Phase: PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated May 13, 2026 16:03 UTC